Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1991-5-29
pubmed:abstractText
Studies on erythropoietin (Epo) are briefly reviewed in their historical perspective from mid 19th century until its identification as a product of genetic recombination and its clinical trials in 1987. Our own work throughout three decades deals mainly with Epo action on RNA biosynthesis in rat bone marrow. Results show that Epo participation as a fundamental compound in the erythropoietic process, inducing the biosynthesis of a giant RNA probably with hnRNA characteristics, which is processed to functional RNA with the participation of testosterone (Te). Despite the so many experimental data available at present, there is still no conclusive evidence allowing to define the specific molecular mechanisms of action of both hormones at transcriptional level. A model is postulated to explain the effects of Epo and Te on RNA biosynthesis. Finally, the implications of present knowledge for the conceptual approach and design of future work are discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0004-0533
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
203-17
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Molecular action of erythropoietin on RNA synthesis: 30 years of study.
pubmed:affiliation
Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago.
pubmed:publicationType
Journal Article, Comparative Study, In Vitro, Review, Research Support, Non-U.S. Gov't